CCO Independent Conference Coverage
American Society of Hematology 2007 Annual Meeting*
December 7-12, 2007 | Atlanta, Georgia
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Chronic Myeloid Leukemia
|
Track 1 of 6
|
|
|
|
Program Director:
Roy A. Beveridge, MD
   |
- Brian Druker, MD
- Charles L. Sawyers, MD
- Moshe Talpaz, MD
|
Moderator:
Allen S. Yang, MD, PhD
|
|
Multiple Myeloma
|
Track 2 of 6
|
|
|
|
Program Director:
Roy A. Beveridge, MD
   |
- Kenneth Anderson, MD
- Sagar Lonial, MD
- Robert Z. Orlowski, MD, PhD
|
Moderator:
Seema Singhal, MD
|
|
Myelodysplastic Syndromes
|
Track 3 of 6
|
|
|
|
Program Director:
Roy A. Beveridge, MD
   |
- Alan F. List, MD
- Azra Raza, MD
- Lewis Silverman, MD
|
Moderator:
Allen S. Yang, MD, PhD
|
|
Acute Leukemias
|
Track 4 of 6
|
|
|
|
Program Director:
Roy A. Beveridge, MD
   |
- Dan Douer, MD
- Stephen J. Forman, MD
- Hagop M. Kantarjian, MD
|
Moderator:
Mark Kirschbaum, MD
|
|
|
|
|
Program Director:
Roy A. Beveridge, MD
   |
- Alexandra M. Levine, MD
- Carol S. Portlock, MD
- Julie M. Vose, MD
|
Moderator:
Robert S. Mocharnuk, MD
|
|
Chronic Lymphocytic Leukemia
|
Track 6 of 6
|
|
|
|
Program Director:
Roy A. Beveridge, MD
   |
- John C. Byrd, MD
- Michael J. Keating, MB BS
- Kanti Rai, MD
|
Moderator:
Robert S. Mocharnuk, MD
|
|
Expert Highlights
Listen to the experts quickly summarize the key issues in hematologic malignancies highlighted at the conference!
|
Julie M. Vose, MD, describes evolving strategies in the treatment of non-Hodgkin’s lymphoma and the incorporation of newer agents into therapy. (5 minutes)
|
 |
Download Audio |
|
Alan F. List, MD, discusses the importance of dosing and scheduling of therapies in myelodysplastic syndrome as well as the biology of the disease, supportive care, and emerging treatments. (5 minutes)
|
|
Download Audio |
|
Michael J. Keating, MB BS, gives an overview of new insights into the genetics, biology, and immunology of chronic lymphocytic leukemia and new advances in chemoimmunotherapy. (6 minutes)
|
|
Download Audio |
|
Moshe Talpaz, MD, describes the emerging data on the treatment of chronic myeloid leukemia, with a discussion of the use of tyrosine kinase inhibitors as well as response characteristics in this patient population. (5 minutes)
|
|
Download Audio |
|
Hagop M. Kantarjian, MD, provides an update on the management of acute leukemias, including a discussion of prognostic markers, optimal induction and maintenance therapies, and new agents. (4 minutes)
|
|
Download Audio |
|
Sagar Lonial, MD, updates maturing clinical trial data in newly diagnosed and relapsed multiple myeloma patients and discusses emerging therapies. (3 minutes)
|
|
Download Audio |
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|